VA

Vijay Arun Khendke

Active Director Designated Partner DIN 11398547
DIN 11398547 First appointment Nov 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Vijay Arun Khendke

Data last updated:

Vijay Arun Khendke is a Designated Partner at Zenvexa Pharmaceuticals Llp (since 2025). The company operates in Pharma.

DIN 11398547
Primary Designation Designated Partner
Industry Pharma
First Appointment 27 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner27 Nov 20252025Active

Board colleagues of Vijay Arun Khendke

NameDINCompanyDesignation
Shubham Dattatray Walunj11398545Zenvexa Pharmaceuticals LlpDesignated Partner
Soham Sunil Mhatre11398546Zenvexa Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Zenvexa Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Vijay Arun Khendke

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijay Arun Khendke

Vijay Arun Khendke currently holds 1 directorship: Zenvexa Pharmaceuticals Llp (Designated Partner, since 27 Nov 2025).

Vijay Arun Khendke was first appointed on 27 Nov 2025 as Designated Partner at Zenvexa Pharmaceuticals Llp.

The current boards of Vijay Arun Khendke's companies include Shubham Dattatray Walunj (Zenvexa Pharmaceuticals Llp), Soham Sunil Mhatre (Zenvexa Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available